Nursing
Pharmacology General Principles Practice Questions
Click on the correct answer.
Most drug have molecular weights between:
- 10 - 100
- 100 and 1000
- 7 - about 60000
- above 60000
- none of the above
Bond type that is seen in some drug-receptor interactions and tends to very strong, often nearly irreversible:
- hydrophobic
- electrostatic
- covalent
- A & C
- B & C
Example(s) of covalent drug-receptor interactions:
- activated phenoxybenzamine-receptor
- anti-cancer DNA alkylating drugs, like cyclophosphamide (Cytoxan)
- norepinephrine
- A & B
- A, B & C
Term having to do with drug actions on the body:
- pharmacokinetics
- pharmacodynamics
- pharmacogenetics
- placebo
- all of the above
General term having to do with actions of the body on the drug:
- pharmacodynamics
- pharmacogenetics
- pharmacokinetics
- absorption
- none of the above
Pharmacological antagonists:
- cause receptor down regulation
- prevent binding of other molecules to the receptor by their binding to the receptor
- atropine (blocks ACh action on the heart
- A & B
- B & C
Drug-transport system described as "energy requiring":
- glomerular filtration
- facilitated diffusion
- active transport
- B & C
- A, B & C
Most important factor influencing drug absorption rate following intramuscular injection:
- needle diameter
- rate of administration
- injection site blood flow
- injection volume
Most common mechanism of drug permeation:
- endocytosis
- carrier-mediated transport
- active-transport
- passive diffusion
- none of the above
Mechanism(s) of drug permeation:
- lipid diffusion
- aqueous diffusion
- use of carrier molecules
- endocytosis and exocytosis
- all of the above
Faster drug absorption:
- lung
- stomach
Drug with this ionization property most likely to diffuse from intestine (pH 8.4) to blood (pH 7.4)
- weak acid (pKa 7.4)
- weak base (pKa 8.4)
- weak acid (pKa 8.4)
- weak base (pKa 6.4)
- weak acid (pKa 6.4)
Increasing ionization at pH ABOVE pKa:
- weak acid
- weak base
Weak organic acid, pKa 6.5. Percent ionization at pH 7.5
- 1%
- 10%
- 50%
- 90%
- 99%
Drug delivery method LEAST suitable for long term (days to weeks) slow release.
- pellet implant under the skin (subcutaneous)
- time release capsule
- i.m. injection of a drug-oil suspension
- transdermal patch
- none of the above
Dramatic decrease in systemic availability of a drug following oral administration is most likely due to:
- extreme drug instability at stomach pH
- hepatic "first-pass" effect
- drug metabolized by gut flora
- tablet does not dissolve
- patient non-complance